Question: A British pharmaceutical company, Glaxo Holdings, has recently developed a new drug for migraine headaches. Among the claims Glaxo made for its drug, called somatriptan, was that the mean time needed for it to enter the blood- stream is less than 10 minutes. To convince the Food and Drug Administration of the validity of this claim, Glaxo conducted an experiment on a randomly chosen set of migraine sufferers. To prove the company’s claim, what should Glaxo have taken as the null and the alternative hypotheses?

Price: $2.99

Solution: The downloadable solution consists of 1 pages
Deliverable: Word Document